In this study, we divided CRC patients into four phenotypic subgroups using immunohistochemistry, and assessed the prognostic role of tissue expressions and serum concentrations of VEGF, bFGF, and PDGF-bb among each subgroup. This evidence concerns the gene FGF2 and colorectal carcinoma.